We look forward to expanding the clinical evaluation to earlier stages of disease progression following recent FDA clearance to initiate clinical development of TSHA102 in pediatric patients in the United States Rumana HaqueAhmed  Senior Vice President Regulatory Affairs of Taysha added Rett syndrome is a devastating neurodevelopmental disorder that can lead to motor and respiratory impairment loss of communication and ultimately shortened life expectancy